NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Advanced gastric cancer
Date of first enrollment	09/09/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Irinotecan and S-1 INN of investigational material : Therapeutic category code : 424 Antineoplastic preparations extracted from plants Dosage and Administration for Investigational material : Irinotecan: injection, S-1: oral

Outcome(s)

Primary Outcome	Overall survival
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 75age old
Gender	Both
Include criteria	Histologically confirmed unresectable or relapsed gastric cancer Neither prior chemotherapy nor prior radiotherapy Age between 20 and 75 years old ECOG Performance Status: 0-2
Exclude criteria